9/28/2020 5:14:30 PM
FDA Approves Pfizer's XELJANZ For Treatment Of Active Polyarticular Course Juvenile Idiopathic Arthritis
9/24/2020 8:07:33 AM
Pfizer Inc. (PFE) Declares $ 0.38 Dividend for Q4 20, Record Date 11/6/2020
9/24/2020 8:04:56 AM
Pfizer Declares Q4 Dividend Of $0.38/shr; Payable December 1/records November 6
9/24/2020 6:01:26 AM
IDEAYA Biosciences Expands Clinical Trial Collaboration And Supply Agreement With Pfizer
9/23/2020 7:08:15 AM
Pfizer Says FDA Accepted And Granted Priority Review To SNDA For XALKORI
9/15/2020 7:01:22 AM
Mylan, Pfizer Receive European Commission Approval For Proposed Combination Of Mylan And Upjohn
9/9/2020 7:49:41 AM
Pfizer And BioNTech Announce Preliminary Preclinical Data Of MRNA-based Vaccine Candidate Against COVID-19
9/9/2020 6:19:31 AM
Pfizer, BioNTech To Potentially Supply EU With 200 Mln Doses Of BNT162 MRNA-based Vaccine Candidate Against SARS-CoV-2